Scientists from Australia and the US are teaming up to tackle devastating African swine fever

Published 2023년 11월 10일

Tridge summary

Scientists from Australia and the US are collaborating to create a safe and effective vaccine for African swine fever (ASF), which is currently devastating the pig industries worldwide. The vaccine is being evaluated in Australia's secure laboratories, as an outbreak in the country could cost up to $2 billion and result in the deaths of infected pigs. MBF Therapeutics and Australia's national science agency, CSIRO, are using innovative DNA vaccine technology to develop a vaccine that is safe for all stages of swine production.
Disclaimer:The above summary was generated by Tridge's proprietary AI model for informational purposes.

Original content

Scientists from Australia and the US are teaming up to tackle devastating African swine fever with a safe and effective vaccine. Regraded as one of animal science's biggest challenges, the aim is to develop a safe and effective vaccine to bring the viral pandemic devastating the world's pig industries under control. Australia's national science agency, CSIRO, and US biotech firm MBF Therapeutics are working together to evaluate a novel DNA vaccine candidate for ASF. While Australia has never had an outbreak of African swine fever, it has recently spread through Asia and is now found in Indonesia, Timor-Leste and Papua New Guinea. It's estimated a large-scale outbreak in Australia would cost the economy up to $2 billion, killing up to 100 per cent of infected pigs. The vaccine will be evaluated in the secure laboratories at CSIRO's Australian Centre for Disease Preparedness in Geelong. African swine fever expert at ACDP, Dr David Williams, said scientists had not yet been able to ...
Source: Farmweekly

Would you like more in-depth insights?

Gain access to detailed market analysis tailored to your business needs.
By clicking “Accept Cookies,” I agree to provide cookies for statistical and personalized preference purposes. To learn more about our cookies, please read our Privacy Policy.